{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:57:49Z","timestamp":1769021869844,"version":"3.49.0"},"reference-count":41,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14601","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T05:16:19Z","timestamp":1722402979000},"source":"Crossref","is-referenced-by-count":3,"title":["Myeloid\/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review"],"prefix":"10.3892","volume":"28","author":[{"given":"Yu-Jie","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Xue","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Nan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shukai","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"key":"key20240906090811_b1-ol-28-4-14601","first-page":"1628","article-title":"A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: A review","volume":"9","author":"Macdonald","year":"1995","journal-title":"Leukemia"},{"key":"key20240906090811_b2-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/gcc.1195","article-title":"Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: The first fusion gene involving BCR but not ABL","volume":"32","author":"Fioretos","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"key20240906090811_b3-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.humpath.2009.11.003","article-title":"8p11 myeloproliferative syndrome: A review","volume":"41","author":"Jackson","year":"2010","journal-title":"Hum Pathol"},{"key":"key20240906090811_b4-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"1015792","DOI":"10.3389\/fonc.2022.1015792","article-title":"The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"key20240906090811_b5-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"key20240906090811_b6-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/00000478-199203000-00003","article-title":"T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy","volume":"16","author":"Abruzzo","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"key20240906090811_b7-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/med.21288","article-title":"FGF receptors: Cancer biology and therapeutics","volume":"34","author":"Katoh","year":"2014","journal-title":"Med Res Rev"},{"key":"key20240906090811_b8-ol-28-4-14601","first-page":"983","article-title":"Clinical significance of FGFR1 gene abnormalities in blood tumors","volume":"28","author":"Zhang","year":"2020","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"key20240906090811_b9-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/gcc.20023","article-title":"Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome","volume":"40","author":"Grand","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"key20240906090811_b10-ol-28-4-14601","first-page":"291","article-title":"Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)","volume":"36","author":"Zhou","year":"2015","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20240906090811_b11-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s10495-013-0886-7","article-title":"Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers","volume":"8","author":"Tiong","year":"2013","journal-title":"Apoptosis"},{"key":"key20240906090811_b12-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cytogfr.2015.03.003","article-title":"Functions of fibroblast growth factor receptors in cancer defined by novel translocations and mutations","volume":"26","author":"Gallo","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20240906090811_b13-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molmed.2011.01.012","article-title":"Targeting mutant fibroblast growth factor receptors in cancer","volume":"17","author":"Greulich","year":"2011","journal-title":"Trends Mol Med"},{"key":"key20240906090811_b14-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1182\/blood-2005-04-1505","article-title":"Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198\/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease","volume":"107","author":"Kasyapa","year":"2006","journal-title":"Blood"},{"key":"key20240906090811_b15-ol-28-4-14601","first-page":"e22734","article-title":"Myeloproliferative syndrome with eosinophilia associated with translocation t(8; 13) and T-cell lymphoblastic lymphoma: A case report and review of the literature","volume":"14","author":"Urrea Pineda","year":"2022","journal-title":"Cureus"},{"key":"key20240906090811_b16-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cancergen.2013.04.001","article-title":"A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment","volume":"206","author":"Buijs","year":"2013","journal-title":"Cancer Genet"},{"key":"key20240906090811_b17-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"14479","DOI":"10.1073\/pnas.0404438101","article-title":"PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20240906090811_b18-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/sj.thj.6200561","article-title":"Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: Two further cases","volume":"5","author":"Vizmanos","year":"2004","journal-title":"Hematol J"},{"key":"key20240906090811_b19-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1182\/blood.V93.4.1381","article-title":"The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1","volume":"93","author":"Popovici","year":"1999","journal-title":"Blood"},{"key":"key20240906090811_b20-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1182\/blood.V95.5.1788.005k15_1788_1796","article-title":"FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)","volume":"95","author":"Guasch","year":"2000","journal-title":"Blood"},{"key":"key20240906090811_b21-ol-28-4-14601","first-page":"297","article-title":"8p11 myeloproliferative syndrome with CEP110-FGFR1 fusion in a child","volume":"57","author":"Chen","year":"2019","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"key20240906090811_b22-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1365-2141.2000.02355.x","article-title":"The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): A novel translocation involving the FGFR1 gene","volume":"111","author":"Mugneret","year":"2000","journal-title":"Br J Haematol"},{"key":"key20240906090811_b23-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/10428194.2019.1660975","article-title":"Leukemic lineage switch in a t(8;22)(p11.2;q11.2)\/BCR-FGFR1-rearranged myeloid\/lymphoid neoplasm with RUNX1 mutation-diagnostic pitfalls and clinical management including FGFR1 inhibitor pemigatinib","volume":"61","author":"Manur","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"key20240906090811_b24-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/leu.2015.136","article-title":"Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia","volume":"30","author":"Khodadoust","year":"2016","journal-title":"Leukemia"},{"key":"key20240906090811_b25-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/sj.leu.2404130","article-title":"NUP98 rearrangements in hematopoietic malignancies: A study of the groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique","volume":"20","author":"Romana","year":"2006","journal-title":"Leukemia"},{"key":"key20240906090811_b26-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1600-0609.2010.01568.x","article-title":"The 8p11 myeloproliferative syndrome owing to rare FGFR1OP2-FGFR1 fusion","volume":"86","author":"Onozawa","year":"2011","journal-title":"Eur J Haematol"},{"key":"key20240906090811_b27-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/gcc.20144","article-title":"8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes","volume":"42","author":"Belloni","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"key20240906090811_b28-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.leu.2403712","article-title":"The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1","volume":"19","author":"Walz","year":"2005","journal-title":"Leukemia"},{"key":"key20240906090811_b29-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gcc.20541","article-title":"The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1","volume":"47","author":"Hidalgo-Curtis","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"key20240906090811_b30-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/leu.2009.79","article-title":"LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome","volume":"23","author":"Soler","year":"2009","journal-title":"Leukemia"},{"key":"key20240906090811_b31-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3324\/haematol.2010.036558","article-title":"The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia\/lymphoma and t(7;8)(q22;p11)","volume":"96","author":"Wasag","year":"2011","journal-title":"Haematologica"},{"key":"key20240906090811_b32-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cancergen.2014.05.011","article-title":"Molecular identification of a TPR-FGFR1 fusion transcript in an adult with myeloproliferative neoplasm, T-lymphoblastic lymphoma, and a t(1;8)(q25;p11.2)","volume":"207","author":"Kim","year":"2014","journal-title":"Cancer Genet"},{"key":"key20240906090811_b33-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/leu.2012.286","article-title":"A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2\/NUP358, in a myeloproliferative\/myelodysplastic neoplasm","volume":"27","author":"Gervais","year":"2013","journal-title":"Leukemia"},{"key":"key20240906090811_b34-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1038\/bcj.2014.86","article-title":"A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation","volume":"4","author":"Nakamura","year":"2014","journal-title":"Blood Cancer J"},{"key":"key20240906090811_b35-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/bjh.16294","article-title":"Identification of a novel TFG-FGFR1 fusion gene in an acute myeloid leukaemia patient with t(3;8)(q12;p11)","volume":"188","author":"Wang","year":"2020","journal-title":"Br J Haematol"},{"key":"key20240906090811_b36-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12935-022-02451-y","article-title":"Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway","volume":"22","author":"Zhang","year":"2022","journal-title":"Cancer Cell Int"},{"key":"key20240906090811_b37-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"e0231877","DOI":"10.1371\/journal.pone.0231877","article-title":"INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models","volume":"15","author":"Liu","year":"2020","journal-title":"PLoS One"},{"key":"key20240906090811_b38-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/cmdc.201800719","article-title":"TAS-120 cancer target binding: Defining reactivity and revealing the first fibroblast growth factor receptor 1 (FGFR1) irreversible structure","volume":"14","author":"Kalyukina","year":"2019","journal-title":"ChemMedChem"},{"key":"key20240906090811_b39-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41375-018-0124-y","article-title":"FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia\/lymphoma syndrome","volume":"32","author":"Hu","year":"2018","journal-title":"Leukemia"},{"key":"key20240906090811_b40-ol-28-4-14601","first-page":"993","article-title":"8p11 myeloproliferative syndrome cured by allogeneic hematopoietic stem cell transplantation: Two case reports and literature review","volume":"45","author":"Xu","year":"2013","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"key20240906090811_b41-ol-28-4-14601","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/bmt.2010.171","article-title":"Early immune reconstitution and efficient graft vs tumor effect after unrelated partially matched double cord blood transplantation in refractory 8p11 syndrome","volume":"46","author":"Larosa","year":"2011","journal-title":"Bone Marrow Transplant"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:08:20Z","timestamp":1725602900000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,7,31]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14601","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]},"article-number":"468"}}